Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company that is dedicated to the development of diagnostic and therapeutic products using targeted radiation. Their mission is to transform the way we detect and treat cancer and rare diseases. Their innovative products use targeted radiation to both image diseases and deliver personalized therapy in areas of significant unmet medical need.

Telix has an extensive portfolio focused on prostate, kidney, brain, and hematologic cancers, as well as rare diseases. They have received regulatory approvals from reputable organizations such as the FDA, TGA, and Health Canada. With a reliable and secure global supply chain, manufacturing, and distribution network, Telix is leading a new era in radiopharmaceuticals.

They are currently conducting more than 20 clinical trials worldwide. Join the Telix Pharmaceuticals team to contribute to their groundbreaking research and innovation in the field of cancer and rare diseases